Jerry A. Taylor

Inhibition of sphingosine-1-phosphate lyase for the treatment of autoimmune disorders.

Alan G. E. Wilson, D. Augeri, S. D. Kimball, 2009, Journal of medicinal chemistry.

Lead optimization and structure-based design of potent and bioavailable deoxycytidine kinase inhibitors.

Alan G. E. Wilson, M. Shen, T. Stouch, 2009, Bioorganic & medicinal chemistry letters.

Cycloaddition Reactions of 1-Phenylseleno-2-(p-toluenesulfonyl)ethyne

M. Parvez, T. G. Back, Jerry A. Taylor, 1999 .

5-Fluorocytosine derivatives as inhibitors of deoxycytidine kinase.

Alan G. E. Wilson, M. Shen, D. Augeri, 2009, Bioorganic & medicinal chemistry letters.

Cycloaddition Reactions of 1-Phenylseleno-2-(p-toluenesulfonyl)ethyne.

M. Parvez, T. G. Back, Jerry A. Taylor, 2010 .

Development of a Robust Manufacturing Route for Molnupiravir, an Antiviral for the Treatment of COVID-19

Michael A. Zompa, E. Sirota, L. Tan, 2021, Organic process research & development.

Discovery of indazole aldosterone synthase (CYP11B2) inhibitors as potential treatments for hypertension.

M. Struthers, D. Macneil, D. Cully, 2017, Bioorganic & medicinal chemistry letters.

Inhibition of sphingosine-1-phosphate lyase for the treatment of autoimmune disorders.

Alan G. E. Wilson, D. Augeri, J. Tarver, 2009, Journal of medicinal chemistry.